Inequities in Glycemic Outcomes for Patients with Type 1 Diabetes: Six Years (2016-2021) Longitudinal Follow-Up by Race and Ethnicity of 36,390 Patients in the T1DX-QI Collaborative
Room 355
Level 3, Ernest N. Morial Convention Center
Q&A with Osagie Ebekozien, MD, MPH, CPHQ
Chief Medical Officer,
T1D Exchange
What is your presentation about?
In this session, we present new data highlighting alarming racial inequities in diabetes device use and glycemic outcomes among a large cohort of people living with type 1 diabetes in the United States. We also share innovative strategies to address some of these inequities using insights from the T1DX-QI Collaborative.
What makes this topic important in 2022?
Inequities in diabetes have been amplified with the COVID-19 pandemic. This session is timely as it highlights both the problem and solutions.
How did you become involved with this area of diabetes research or care?
I started my diabetes research journey as a researcher focused on diabetes health inequities and social determinants of health.
What are you most looking forward to at the 82nd Scientific Sessions?
Meeting existing collaborators and making new friends.
[sub-post-content]